Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/8216Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Georgiou, E. | en |
| dc.contributor.author | Metsios, A. | en |
| dc.contributor.author | Kourkoumelis, N. | en |
| dc.contributor.author | Karkabounas, S. | en |
| dc.contributor.author | Charalabopoulos, K. | en |
| dc.contributor.author | Badeka, A. | en |
| dc.contributor.author | Hadjikakou, S. K. | en |
| dc.date.accessioned | 2015-11-24T16:40:00Z | - |
| dc.date.available | 2015-11-24T16:40:00Z | - |
| dc.identifier.issn | 1475-6366 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/8216 | - |
| dc.rights | Default Licence | - |
| dc.subject | bioinorganic chemistry | en |
| dc.subject | gold(i) complexes | en |
| dc.subject | thioamides | en |
| dc.subject | biological studies | en |
| dc.subject | lipoxygenase inhibition | en |
| dc.subject | linoleic-acid | en |
| dc.subject | organotin(iv) | en |
| dc.subject | derivatives | en |
| dc.subject | silver(i) | en |
| dc.title | Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.primary | Doi 10.3109/14756366.2010.529807 | - |
| heal.identifier.secondary | <Go to ISI>://000292266000018 | - |
| heal.identifier.secondary | http://informahealthcare.com/doi/abs/10.3109/14756366.2010.529807 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείας | el |
| heal.publicationDate | 2011 | - |
| heal.abstract | Four mixed ligand gold(I) complexes with the thioamides 2-mercapto-thiazolidine (mtzdH), 2-mercapto-benzothiazole (mbztH) and 5-chloro-2-mercapto-benzothiazole (ClmbztH) and triphenylphosphine (tpp) of formulae [Au(tpp) Cl] (1) [Au(tpp)(mtzd)] (2), [Au(tpp)(mbzt)] (3) and [Au(tpp)(Clmbzt)] (4), already known, were used to study their mechanism of inhibition activity towards the catalytic oxidation of linoleic acid to hydroperoxylinoleic acid by the enzyme lipoxygenase (LOX), kinetically and theoretically. The results are compared to those of cisplatin. In addition, the anticancer cell screening results against leimyosarcoma (LMS) cells have shown that 2-4 complexes were more active than cisplatin. The uptake of complexes in LMS cells were also studied with electrospray ionisation mass spectrometry spectroscopy. | en |
| heal.publisher | Informa Healthcare | en |
| heal.journalName | J Enzyme Inhib Med Chem | en |
| heal.journalType | peer reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
